thiazoles has been researched along with stavudine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baba, M; De Clercq, E; Desmyter, J; Nakashima, H; Pauwels, R; Schols, D | 1 |
Cheng, B | 1 |
Smart, T | 1 |
Shegokar, R; Singh, KK | 1 |
6 other study(ies) available for thiazoles and stavudine
Article | Year |
---|---|
Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds.
Topics: Antiviral Agents; Cell Line; Dideoxynucleosides; HIV-1; HIV-2; Pentosan Sulfuric Polyester; Staining and Labeling; Stavudine; Tetrazolium Salts; Thiazoles; Viral Plaque Assay; Zidovudine | 1989 |
New drugs for HIV infection.
Topics: Antiviral Agents; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Zalcitabine | 1996 |
Protease inhibitor trials moving to next phase.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication | 1995 |
Update on protease inhibitors.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Placebos; Pyridines; Ritonavir; Stavudine; Thiazoles; Valine | 1996 |
Nipping HIV in the bud.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine | 1996 |
Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirs.
Topics: Animals; Anti-HIV Agents; Calorimetry, Differential Scanning; Cell Survival; Coloring Agents; Drug Compounding; Electrochemistry; Fluorescent Dyes; HIV; HIV Seropositivity; In Vitro Techniques; Lymphatic System; Macrophages; Male; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Particle Size; Rats; Rats, Wistar; Rhodamine 123; Stavudine; Tetrazolium Salts; Thiazoles; Tissue Distribution | 2011 |